{
  "nctId": "NCT02972502",
  "briefTitle": "Efficacy of Haloperidol vs. Metoclopramide for Treatment of Acute Headaches and Migraines in the Emergency Department",
  "officialTitle": "Investigating the Efficacy of Using Haloperidol vs. Metoclopramide for Treatment of Acute Headaches and Migraines in the Emergency Department: A Prospective Randomized Clinical Trial",
  "protocolDocument": {
    "nctId": "NCT02972502",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2016-05-16",
    "uploadDate": "2018-07-19T16:21",
    "size": 148906,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT02972502/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "PHASE4"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "SINGLE",
  "enrollmentInfo": {
    "enrollmentCount": 66,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2014-02",
    "completionDate": "2017-04-24",
    "primaryCompletionDate": "2017-04-24",
    "firstSubmitDate": "2016-11-07",
    "firstPostDate": "2016-11-23"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Patients who present with a headache or migraine with onset less than or equal to 72 hours\n\nExclusion Criteria:\n\n* Known pregnancy\n* Breast-feeding women\n* Known history of arrhythmias or QT prolongation (450 ms)\n* Known adverse effects to haloperidol, diphenhydramine (Benadryl) or metoclopramide\n* Subarachnoid hemorrhage\n* Headaches caused by trauma, meningitis\n* Congestive heart failure\n* Parkinson's Disease\n* Dementia\n* Pheochromocytoma\n* History of glaucoma\n* History of seizures\n* Non-English speaking patients",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Change in Pain Score According to the Numeric Pain Intensity Scale",
        "description": "Numeric Pain Intensity scale is a standard rating tool for pain, ranging from 0-10, with 0=no pain and 10=worst pain imaginable.",
        "timeFrame": "Change from baseline (prior to treatment) to 1 hour post treatment (1 hour)"
      }
    ],
    "secondary": [
      {
        "measure": "Need for Additional Medications Used in the Emergency Department (ED)",
        "description": "Need for additional medications in the ED will be evaluated via chart review at 48 hours post discharge",
        "timeFrame": "48 hours post discharge"
      },
      {
        "measure": "Occurrence of Patient Return to the Emergency Department (ED) or Other Healthcare Provider for Headache/Migraine Within 48 Hours of ED Discharge",
        "description": "Occurrence of patient return to the ED or other healthcare provider for headache/migraine within 48 hours of ED discharge will be evaluated via chart review at 48 hours post discharge",
        "timeFrame": "48 hours post discharge"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 2,
      "otherCount": 0,
      "totalCount": 3
    },
    "studyDesign": {
      "phases": [
        "PHASE4"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 49,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-22T02:29:53.315Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}